Safety, Tolerability, PK, PD, Immunogenicity and Efficacy of TWP-102 in Patients With Advanced Malignancies.
Clinical trial NCT05024305 · UNKNOWN
Trial details
- NCT number
- NCT05024305
- Sponsor
- Shandong TheraWisdom Biopharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-08
- Primary completion
- 2022-12-31
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.